A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Completed · Not applicable

Conditions studied: HIV Infections

In brief

The purpose of this study is to compare 2 combination drug therapies in HIV-infected patients who have never received anti-HIV treatment.

Key facts

Study ID

NCT00002216

Run by

Glaxo Wellcome

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have:
• CD4 count > 50.
• HIV RNA > 5,000.
• No active AIDS (excluding CD4 count < 200).
• Ability to comply with dosing schedule and protocol evaluations.
• Prior Medication:
• Allowed:
• 3TC or any protease inhibitor, if < 1 week of therapy.
• Other nucleoside analogs, if < 4 weeks of therapy.

You may not qualify if…

• Co-existing Condition:
• Patients with any of the following symptoms or conditions are excluded:
• Active AIDS (not including CD4 count < 200).
• Malabsorption syndrome affecting drug absorption.
• Concurrent Medication:
• Excluded:
• Enrollment in any other investigational drug protocol.
• Prior Medication:
• Excluded:
• Non-nucleoside reverse transcriptase inhibitors.

Where it is running

• Anderson Clinical Research — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.